Published in Cryobiology on February 01, 1977
Adjuvant approaches to enhance cryosurgery. J Biomech Eng (2009) 0.82
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Aetiology of Kaposi's sarcoma. Lancet (1990) 1.95
Tissue- and species-specific antigens of normal human prostatic tissue. J Immunol (1970) 1.22
The effect of estrogen on the incorporation of 3H-thymidine by PHA-stimulated human peripheral blood lymphocytes. J Immunol (1974) 1.21
Involvement of the genitourinary system in multiple primary malignant neoplasms: a review. J Clin Oncol (1983) 1.18
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Thymus-specific antigens on human thymocytes and on thymic-derived lymphocytes. Transplantation (1973) 1.10
IgE in pemphigus. Arch Dermatol (1977) 1.09
Immunologic studies of normal, benign, and malignant human prostatic tissue. Cancer (1972) 1.09
Precipitating antigens of the normal human prostate. J Reprod Fertil (1970) 1.04
Early demonstration of renal collateral arterial suppl. Am J Roentgenol Radium Ther Nucl Med (1968) 1.04
Anatomical incidence of testicular appendages. J Urol (1968) 1.03
Pemphigus-like antibodies in patients with skin burns. Vox Sang (1969) 1.02
Urethral diverticular carcinoma. Cancer (1992) 1.01
Precipitating antibody in the sera of patients treated cryosurgically for carcinoma of the prostate. Exp Med Surg (1969) 0.98
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. J Am Coll Surg (1995) 0.98
Serum proteins in patients with benign and malignant diseases of the prostate. Neoplasma (1971) 0.97
Blood product immunosuppression and the acquired immunodeficiency syndrome. Ann Intern Med (1986) 0.97
Odor threshold and gas-chromatographic assays of vaginal odors: changes with nitrofurazone treatment. J Pharm Sci (1970) 0.96
The accuracy of the rectal examination in the diagnosis of prostate carcinoma. N Engl J Med (1980) 0.94
In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells. Anticancer Res (2009) 0.92
Alterations of alpha2-globulin and the clinical response in patients with prostatic cancer following cryotherapy. Oncology (1975) 0.91
Changes in radical prostatectomy and radiation therapy rates for African Americans and whites. J Natl Med Assoc (2000) 0.90
Tissue- and species-specific antibodies in antithymocyte globulin. Transplantation (1972) 0.90
Localization of immunoglobulins in human prostatic tissue. J Immunol (1971) 0.90
Carcinoembryonic antigen in patients with tumors of the urogenital tract. Cancer (1972) 0.89
Benign fibrous ureteral polyps. Urology (1987) 0.89
Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res (1978) 0.89
Hormonal therapy and alteration of lymphocyte proliferation. J Lab Clin Med (1976) 0.89
Immunochemical characterization of epithelial antigen(s) reactive with pemphigus-like antibodies of rabbit and human pemphigus autoantibodies. J Hyg Epidemiol Microbiol Immunol (1969) 0.87
The female prostate and prostate-specific antigen. Immunohistochemical localization, implications of this prostate marker in women and reasons for using the term "prostate" in the human female. Histol Histopathol (2000) 0.87
Long-term complete remission in bladder carcinoma in situ with intravesical TICE bacillus Calmette Guerin. Overview analysis of six phase II clinical trials. Urology (1991) 0.87
Immunobiology of the Dunning R-3327 rat prostate adenocarcinoma sublines: plasma and tumor effusion prostaglandins. Am J Reprod Immunol Microbiol (1985) 0.87
Condylomata acuminata: treatment by autogenous vaccine. IMJ Ill Med J (1975) 0.87
An evaluation of prostate specific antigen in prostatic cancer. J Urol (1987) 0.87
Renal cell carcinoma: the size variable. J Surg Oncol (1993) 0.86
Cancer, immunological surveillance, and 2 -globulin. Lancet (1972) 0.86
Prostate cancer: the stage disadvantage in the black male. J Natl Med Assoc (1991) 0.85
Multiple primary tumors in a 72-year-old woman. J Urol (1983) 0.85
Leukocyte adherence inhibition and immunoreactivity in prostatic cancer. I. Identification of anti-tumour cell-mediated immunity and "blocking" factor. Eur J Cancer (1977) 0.85
Hypertension in a child caused by a multicystic kidney. J Urol (1970) 0.85
Bacillus calmette-guerin (BCG) adjuvant therapy in stage D prostate cancer. Urology (1982) 0.85
Immunosuppressive effects of antimacrophage serum and antithymocyte serum on mouse skin allografts. J Med (1972) 0.84
Lipofuscin granules in normal, benign and malignant human prostatic tissue. Urol Res (1973) 0.84
In vivo establishment of T98G human glioblastoma. Methods Find Exp Clin Pharmacol (1999) 0.84
Immunopathologic studies of experimental pemphigus-like autoantibodies and bullous-like lesions. J Invest Dermatol (1969) 0.83
Transglutaminase: co-factor in aetiology of AIDS? Lancet (1985) 0.83
Immunosuppression of cell- and serum-medicated tumour-associated immunity in prostatic cancer by human seminal plasma. Eur J Cancer (1980) 0.82
An evaluation of the markers p53 and Ki-67 for their predictive value in prostate cancer. J Surg Oncol (1998) 0.82
In vivo bound immunoglobulins in the human prostate--their identification and possible significance. Z Immunitatsforsch Exp Klin Immunol (1972) 0.82
A retrospective look at studies on prostate-specific antigen. Clin Chem (1985) 0.82
A tissue type transglutaminase in human seminal plasma. Am J Reprod Immunol (1997) 0.82
Transperitoneal vesical bivalve in repair of recurrent vesicovaginal fistula. Obstet Gynecol (1973) 0.82
Adjuvant immunotherapy (BCG) in stage D prostate cancer. Am J Clin Oncol (1982) 0.82
Resection of the vena cava for renal cell carcinoma: an experimental study. J Urol (1972) 0.82
Prostaglandin modulation of prostate tumor growth and metastases. Anticancer Res (1986) 0.82
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer. J Clin Oncol (1987) 0.81
The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anticancer Res (2007) 0.81
Evaluation of cytologic techniques for diagnosis of prostate cancer. Urology (1983) 0.81
Prostate cancer and the multiple primary malignant neoplasm syndrome. Prostate (1983) 0.81
Fluorescent studies of antibodies to rabbit male urogenital tissue. Experientia (1969) 0.81
Antiepithelial antibodies in the serum of patients with benign and malignant diseases of the prostate. Z Immunitatsforsch Exp Klin Immunol (1973) 0.81
Immunologic sequelae of thermal injury. I. Frequency and relationship of epithelial antibodies to extent of burn. Clin Immunol Immunopathol (1976) 0.81
Giant hydronephrosis in horseshoe kidney, presenting as right upper quadrant mass and jaundice. Chic Med Sch Q (1970) 0.81
Fibrinolysis resistant fibrin deposits in lymph nodes with Hodgkin's disease. Thromb Haemost (1988) 0.81
Autoallergy in pemphigus. Lancet (1968) 0.81
Freezing of the esophagus: histological changes and immunological response. Int Surg (1982) 0.81
Condyloma acuminatum in a 2 1/2-year-old girl. J Urol (1983) 0.81
Prognostic value of cell surface antigens using immunoperoxidase methods in bladder carcinoma. Urology (1982) 0.81
Letter: Antiepithelial antibodies: a possible clue to malignant neoplasms. Arch Dermatol (1974) 0.81
Stage IV renal cell carcinoma. J Urol (1994) 0.81
Cryosurgery of the rabbit prostate. Comparison of the immune response of immature and mature bucks. Cryobiology (1974) 0.81
Decreased survival of black Americans with testicular cancer. J Urol (1998) 0.80
Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice. J Surg Oncol (1996) 0.80
Lymphocele formation after extraperitoneal pelvic lymphadenectomy: possible predisposing factors. J Urol (1986) 0.80
Carcinoembryonic antigen in the diagnosis of prostate carcinoma. Oncology (1974) 0.80
Bone scan as a stratification variable in advanced prostate cancer. Cancer (1991) 0.80
Absorption studies on antigen(s) of the esophageal mucosa reactive with autoantibodies of pemphigus. Int Arch Allergy Appl Immunol (1968) 0.80
Suppression of tumor-associated immunity by human seminal plasma and its possible role in the natural history of prostatic cancer. Eur Urol (1980) 0.80
Modulatory effects of estrogen on immunologic responsiveness. III. Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in prostatic cancer. Am J Reprod Immunol (1981) 0.79
Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells. Med Oncol (2013) 0.79
Androgens and oestrogens may modulate the growth and function of lymphoid organs. J Immunol (1984) 0.79
Immunotherapy for prostatic cancer. Previous and prospective considerations. Oncology (1975) 0.79
Enhanced expression of bcl-2 following antisense oligonucleotide mediated growth factor deprivation. Med Oncol (1997) 0.79
Anti-tissue IgG antibodies and deficiency of IgA. Vox Sang (1972) 0.79
Retinal artery changes correlated with other hypertensive parameters in a coronary heart disease case-history study. Br Heart J (1968) 0.79